Gonadotropin releasing hormone antagonists and cryopreservation outcome: A review

被引：3

作者：

Nikolettos N. ^{[1
]}

Asimakopoulos B. ^{[1
]}

Simopoulou M. ^{[1
]}

Al-Hasani S. ^{[2
]}

Diedrich K. ^{[2
]}

机构：

[1] Lab. of Reproductive Physiology-IVF, Faculty of Medicine, Democritus University of Thrace, 68100 Dragana, Alexandroupolis

[2] Department of Obstetrics, Medical University Lübeck, 23538 Lübeck

来源：

Archives of Gynecology and Obstetrics | 2004年 / 270卷 / 2期

关键词：

Cryopreservation; GnRH-agonist; GnRH-antagonist; In-vitro fertilisation;

D O I：

10.1007/s00404-003-0597-3

中图分类号：

学科分类号：

摘要：

Review: The outcome of freeze-thaw cycles with pronuclear stage oocytes or embryos, derived from collecting cycles stimulated with gonadotropin-releasing hormone (GnRH)-antagonists' protocols, was reviewed. Conclusion: The viability of cryopreserved pronuclear stage oocytes and embryos, the quality of transferred embryos and the pregnancy rates of the freeze-thaw cycles seem to be satisfactory regardless of the type and dose of GnRH-antagonist.

引用

页码：69 / 73

页数：4

共 52 条

[21]

Hershkovitz E., Marbach M., Bosin E., Levy J., Roberts C.T., LeRoith Jr. D., Schally A.V., Sharoni Y., Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors, J Clin Endocrinol Metab, 77, pp. 963-968, (1993)

[22]

Hsueh A.J., Jones P.B., Extrapituitary actions of gonadotrophin-releasing hormone, Endocr Rev, 2, pp. 431-461, (1981)

[23]

Kang S.K., Choi K.C., Tai C.J., Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells, Endocrinology, 142, pp. 580-588, (2001)

[24]

Karten M.J., Rivier J.E., Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: Rationale and perspective, Endocr Rev, 7, pp. 44-46, (1986)

[25]

Kleinman D., Roberts C.T., LeRoith D., Schally A.V., Levy J., Sharoni Y., Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75, Regul Pept, 48, pp. 91-98, (1993)

[26]

Klingmuller D., Schepke M., Enzweiler C., Bidlingmaier F., Hormonal response to the new GnRH-antagonist Cetrorelix, Acta Endocrinol, 128, pp. 15-18, (1993)

[27]

Kol S., GnRH antagonists in ART: Lower embryo implantation?, Hum Reprod, 15, pp. 1881-1882, (2000)

[28]

Kol S., Lightman A., Hillensjo T., Devroey P., Fauser B., Tarlatzis B., Mannaerts B., Itskovitz-Eldor J., High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles, Hum Reprod, 14, pp. 2242-2244, (1999)

[29]

Kolibianakis E., Bourgain C., Albano C., Osmanagaoglu K., Smitz J., Van Steirteghem A., Devroey P., Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up, Fertil Steril, 78, pp. 1025-1029, (2002)

[30]

Latouche J., Crumeyrolle-Arias M., Jordan D., Kopp N., Augendre-Ferrante B., Cedard L., Haour F., GnRH receptors in human granulosa cells: Anatomical localization and characterization by autoradiographic study, Endocrinology, 125, pp. 1739-1741, (1989)

← 1 2 3 4 5 6 →